AEHR TEST SYSTEMS
Business
AEHR TEST SYSTEMS provides test and reliability solutions for testing, burn-in and stabilizing semiconductor devices at wafer level, singulated die and packaged part form. Its product offerings include the FOX family of full-wafer and singulated-die test and burn-in systems, WaferPak contactors and aligners, DiePak carriers and loaders, and packaged-part burn-in platforms (Sonoma, Tahoe and Echo), plus installation, service and support. The company reports a single business segment focused on designing, manufacturing, marketing and selling advanced test and burn-in products, including distinct wafer-level and packaged-part product lines. It sells globally to semiconductor manufacturers, contract assemblers, electronics manufacturers and independent test labs through direct sales, regional offices and a network of distributors and representatives.
Summary from filing dated 2025-07-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-05-31 | FY 2024 2024-05-31 | FY 2023 2023-05-31 | FY 2022 2022-05-31 | FY 2021 2021-05-31 |
|---|---|---|---|---|---|---|
| Revenue | 59 | 66 | 65 | 51 | 17 | |
| Cost of revenue | 35 | 34 | 32 | 27 | 11 | |
| Gross profit | 24 | 33 | 33 | 24 | 6 | |
| Research and development | 10 | 9 | 7 | 6 | 4 | |
| Selling, general and administrative | 18 | 14 | 12 | 10 | 7 | |
| Restructuring charges | 864,000 | 0 | 0 | 0 | 0 | |
| Total operating expenses | 30 | 22 | 19 | 16 | 10 | |
| Income (loss) from operations | −6 | 10 | 13 | 8 | −4 | |
| Interest income, net | 1 | 2 | 1 | 13,000 | −46,000 | |
| Other expense, net | −15,000 | −8,000 | −3,000 | 30,000 | −162,000 | |
| Income (loss) before income tax expense (benefit) | −4 | 12 | 15 | 10 | −2 | |
| Income tax expense (benefit) | −381,000 | −21 | 60,000 | 91,000 | 177,000 | |
| Net income (loss) | −4 | 33 | 15 | 9 | −2 | |
| Basic (per share) | −0.13 | 1.15 | 0.52 | 0.36 | −0.09 | |
| Diluted (per share) | −0.13 | 1.12 | 0.5 | 0.34 | −0.09 | |
| Basic (shares) | 30 | 29 | 28 | 26 | — | |
| Diluted (shares) | 30 | 30 | 29 | 28 | 23 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-05-31 | FY 2024 2024-05-31 | FY 2023 2023-05-31 | FY 2022 2022-05-31 | FY 2021 2021-05-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 25 | 49 | 30 | 31 | 5 | |
| Accounts receivable | 14 | 10 | 17 | — | — | |
| Inventories | 42 | 37 | 24 | 15 | 9 | |
| Prepaid expenses and other current assets | 8 | 1 | 621,000 | 613,000 | 551,000 | |
| Total current assets | 89 | 98 | 89 | 60 | 19 | |
| Property and equipment, net | 9 | 3 | 3 | 1 | 677,000 | |
| Goodwill | 11 | 0 | — | — | — | |
| Intangible assets, net | 11 | 0 | — | — | — | |
| Deferred tax assets, net | 19 | 21 | 0 | — | — | |
| Operating lease right-of-use assets, net | 10 | 6 | 6 | 917,000 | 2 | |
| Other non-current assets | 546,000 | 304,000 | 231,000 | 201,000 | 198,000 | |
| Total assets | 149 | 128 | 98 | 62 | 22 | |
| Accounts payable | 7 | 5 | 9 | 4 | 3 | |
| Accrued expenses and other current liabilities | 6 | 3 | — | — | — | |
| Operating lease liabilities, short-term | 909,000 | 465,000 | 137,000 | 794,000 | 737,000 | |
| Deferred revenue, short-term | 2 | 1 | 3 | — | — | |
| Total current liabilities | 16 | 11 | 16 | 11 | 9 | |
| Operating lease liabilities, long-term | 10 | 6 | 6 | 212,000 | 1 | |
| Deferred revenue, long-term | 36,000 | 41,000 | 31,000 | 69,000 | 99,000 | |
| Other long-term liabilities | 42,000 | 38,000 | 41,000 | 44,000 | — | |
| Total liabilities | 26 | 16 | 23 | 11 | 10 | |
| Preferred stock, $0.01 par value: Authorized: 10,000 shares; Issued and outstanding: none | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.01 par value: Authorized: 75,000 shares; Issued and outstanding: 29,877 shares and 28,995 shares at May 30, 2025 and May 31, 2024, respectively | 299,000 | 289,000 | 285,000 | 271,000 | 237,000 | |
| Additional paid-in capital | 146 | 131 | 128 | 118 | 88 | |
| Accumulated other comprehensive loss | −126,000 | −158,000 | −155,000 | −105,000 | −28,000 | |
| Accumulated deficit | −23 | −19 | −52 | −67 | −76 | |
| Total shareholders' equity | 123 | 112 | 76 | 51 | 11 | |
| Total liabilities and shareholders equity | 149 | 128 | 98 | 62 | 22 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-05-31 | FY 2024 2024-05-31 | FY 2023 2023-05-31 | FY 2022 2022-05-31 | FY 2021 2021-05-31 |
|---|---|---|---|---|---|---|
| Net income (loss) | −4 | 33 | 15 | — | — | |
| Stock-based compensation expense | 5 | 3 | 3 | 3 | 1 | |
| Depreciation and amortization | 2 | 657,000 | 450,000 | 356,000 | 328,000 | |
| Deferred income taxes | −421,000 | −21 | 0 | 0 | — | |
| Amortization of operating lease right-of-use assets | 1 | 706,000 | 649,000 | 689,000 | — | |
| Impairment of assets | 584,000 | 0 | 0 | — | — | |
| Accretion of investment discount | 0 | −130,000 | −576,000 | 0 | 0 | |
| Provision for credit losses | 0 | 0 | 24,000 | 0 | — | |
| Accounts receivable | −3 | 7 | −4 | −8 | −1 | |
| Inventories | −2 | −14 | −9 | −7 | −972,000 | |
| Prepaid expenses and other current assets | −5 | −875,000 | 28,000 | −71,000 | — | |
| Accounts payable | −714,000 | −4 | 5 | 1 | 2 | |
| Accrued expenses | −378,000 | −792,000 | 528,000 | 1 | 732,000 | |
| Deferred revenue | 143,000 | −1 | 369,000 | 2 | — | |
| Operating lease liabilities | −699,000 | −423,000 | −561,000 | −738,000 | — | |
| Income taxes payable | −65,000 | 14,000 | 8,000 | 6,000 | −10,000 | |
| Net cash provided by (used in) operating activities | −7 | 2 | 10 | 2 | −3 | |
| Payments for business acquisition, net of cash and cash equivalent acquired | −11 | 0 | 0 | — | — | |
| Purchases of property and equipment | −5 | −749,000 | −1 | −416,000 | −227,000 | |
| Proceeds from maturities of investments | 0 | 18 | 16 | 0 | 0 | |
| Purchases of investments | 0 | 0 | −33 | 0 | 0 | |
| Net cash provided by (used in) investing activities | −16 | 17 | −19 | −416,000 | −227,000 | |
| Proceeds from issuance of common stock under employee plans | 1 | 2 | 3 | 4 | 580,000 | |
| Shares repurchased for tax withholdings on vesting of restricted stock units and in connection with the termination of the ESOP | −784,000 | −2 | −2 | −429,000 | −20,000 | |
| Proceeds from issuance of common stock, net of issuance costs | 0 | −72,000 | 7 | 24 | 0 | |
| Net cash provided by financing activities | 625,000 | 139,000 | 7 | 26 | 2 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 13,000 | −41,000 | −37,000 | 49,000 | 117,000 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | −23 | 19 | −1 | 27 | −851,000 | |
| Income taxes paid | 100,000 | 90,000 | 21,000 | 4,000 | 15,000 | |
| Interest paid | 0 | 0 | 15,000 | 12,000 | 6,000 | |
| Net transfer of equipment between inventory and property and equipment | 458,000 | 357,000 | 646,000 | 472,000 | 113,000 | |
| Purchases of property and equipment included in accounts payable and accrued liabilities | 1 | 53,000 | 698,000 | — | — |